Product Description: Saudin, derived from Clutia lanceolata, is a hypoglycemic compound that significantly enhances glucose-triggered insulin release from murine pancreatic islets. It belongs to a group of new diterpenoids with a distinct tetracyclic core, suggesting potential as a therapeutic agent for diabetes treatment. Proposed biosynthetic pathways outline alternative cyclization routes from a common precursor, with Lanceolide P (16) identified as a promising lead compound for further development in managing diabetes[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C20H22O7
References: [1]Compounds Related to Saudin and Three New Series of Diterpenoids from Clutia lanceolata
CAS Number: 94978-16-2
Molecular Weight: 374.38
Research Area: Endocrinology
Target: Others